Canopy Growth Corporation
TSX:WEED.TO · Toronto Stock Exchange
+$0.03 today
Vol 0.48M · Avg 2.07M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-37.7%
avg -75.5%
ROIC
-7.4%
avg -12.0%
ROA
-23.5%
avg -31.0%
Analysis
ROIC is currently the strongest return metric at -7.4% versus its period average of -12.0%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Luc Mongeau | Chief Executive Officer & Director | $2.09M | — | 58 | — | — |
Christelle Gedeon | Chief Business Development & Corporate Affairs Officer | $824,460.00 | — | 43 | — | — |
Thomas Carlton Stewart | Chief Accounting Officer & Chief Financial Officer | $482,036.00 | — | 44 | — | — |
Jason Green | Head of Agriculture - Hemp Division | — | — | — | — | — |
Chrissy McHardy | Senior Vice President of Human Resources | — | — | — | — | — |
Tyler Burns | Director of Investor Relations | — | — | — | — | — |
Andrew Bevan | Senior Vice President of Medical Sales | — | — | — | — | — |
Michael Perron | Chief Operating Officer | — | — | — | — | — |
Miles Worne | Managing Director of European Markets | — | — | — | — | — |
David Manner | Managing Director of Storz & Bickel GmbH | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +635.7% | +36.1% (17yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Recent growth has been strongest in Revenue at +635.7% over three years. Forward estimates point to Revenue at +36.1% (17yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Cipher Pharmaceuticals Inc.
TSX:CPH.TO
$408.04M
NervGen Pharma Corp.
NGEN.V
$407.94M
Spectral Medical Inc.
TSX:EDT.TO
$399.05M
Fennec Pharmaceuticals Inc.
TSX:FRX.TO
$360.97M
High Tide Inc.
HITI.V
$289.09M
TerrAscend Corp.
TSX:TSND.TO
$283.25M
Aurora Cannabis Inc.
TSX:ACB.TO
$256.44M
Auxly Cannabis Group Inc.
TSX:XLY.TO
$250.54M
OrganiGram Holdings Inc.
TSX:OGI.TO
$187.64M
Jushi Holdings Inc.
JUSH.CN
$133.80M
Who manages WEED.TO?
Canopy Growth Corporation (WEED.TO) lists 10 active executives. The top listed executive is Jason Green, Head of Agriculture - Hemp Division.
Explore More
Continue the stock analysis
Jump to another research area for this company.